Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration

Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration

Luis Arias1,2, Jordi Mon&eacute;s11Institut de la M&agrave;cula i de la Retina, Centro M&eacute;dico Teknon, Barcelona; 2Hospital Universitari de Bellvitge, L&rsquo;Hospitalet de Llobregat, BarcelonaPurpose: To determine the efficacy and safety of treating predominant...

Full description

Bibliographic Details
Main Authors:	Luis Arias, Jordi Mon&eacute;s
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-02-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/transconjunctival-sutureless-vitrectomy-with-tissue-plasminogen-activa-a3949

Similar Items

Clinical effect of 23G transconjunctival sutureless vitrectomy for idiopathic macular hole
by: Wei Cao, et al.
Published: (2014-06-01)

Learning curve of sutureless transconjunctival 20-gauge vitrectomy
by: Simanjuntak GWS, et al.
Published: (2014-07-01)

Acute endophthalmitis following 23-gauge sutureless transconjunctival vitrectomy
by: Çekiç Osman, et al.
Published: (2011-01-01)

Outcomes of transconjunctival sutureless 27-gauge vitrectomy for vitreoretinal diseases
by: Jie Li, et al.
Published: (2018-03-01)

Sympathetic ophthalmia after 23-gauge transconjunctival sutureless vitrectomy
by: Masatoshi Haruta, et al.
Published: (2010-11-01)

Bacterial endophthalmitis following 25-gauge transconjunctival sutureless vitrectomy
by: Drew N Sommerville, et al.
Published: (2008-09-01)

Incidence of rebleed following 23 gauge transconjunctival sutureless vitrectomy for vitreous hemorrhage due to vascular etiologies
by: Manish Nagpal, et al.
Published: (2013-01-01)

Subconjunctival Injection of Viscoelastic Material for Leaking Sclerotomy in Transconjunctival Sutureless Vitrectomy
by: Chung Hyun Lee, et al.
Published: (2016-01-01)

Primary 25-gauge transconjunctival sutureless vitrectomy in pseudophakic retinal detachment
by: Horozoglu Fatih, et al.
Published: (2007-01-01)

Primary 25-guage transconjunctival sutureless vitrectomy in pseudophakic retinal detachment
by: Dubey Arvind, et al.
Published: (2008-01-01)

Gauge Transconjunctival Sutureless Vitrectomy in Eyes with Posteriorly Dislocated Intraocular Lens
by: Hüseyin Dündar, et al.
Published: (2013-04-01)

Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection
by: Erakgun Tansu, et al.
Published: (2009-01-01)

Combined Femtosecond Laser-Assisted Cataract Surgery and 27-Gauge Transconjunctival Sutureless Vitrectomy
by: Sami Yılmaz, et al.
Published: (2020-01-01)

Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration
by: Mustafa Gok, et al.
Published: (2017-01-01)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
by: Kumagai K, et al.
Published: (2019-04-01)

Comparison between 20-, 23-, and 25-G transconjunctival sutureless vitrectomy in the surgical treatment of idiopathic macular hole and idiopathic epiretinal membrane
by: Ahmed M Bedda, et al.
Published: (2016-01-01)

Outcome of 20-gauge transconjunctival cannulated sutureless vitrectomy using silicone oil or air tamponade
by: Mohamed AA, et al.
Published: (2013-02-01)

23-gauge Transconjunctival Sutureless Vitrectomy in Eyes with Posteriorly Dislocated Intraocular Lens after Cataract Surgery
by: Fatih Horozo¤lu, et al.
Published: (2011-08-01)

Intravitreous Recombinant Tissue Plasminogen Activator and Gas to Treat Submacular Hemorrhage in Age-Related Macular Degeneration
by: San-Chang Tsai, et al.
Published: (2003-12-01)

′Sutureless′ transconjunctival approach for infraorbital rim fractures
by: Vaibhav Nagaraj, et al.
Published: (2015-01-01)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
by: Ramin Nourinia, et al.
Published: (2010-01-01)

Factors influencing self-sealing of sclerotomy performed under gas tamponade in 23-gauge transconjunctival sutureless vitrectomy
by: Takashina H, et al.
Published: (2014-10-01)

Study of modified two incisions silicone oil removal with a 23G transconjunctival sutureless vitrectomy system
by: Hai-Jun Yang, et al.
Published: (2015-01-01)

Sutureless vitrectomy
by: Warrier Sunil, et al.
Published: (2008-01-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
by: Joel Hanhart, et al.
Published: (2017-10-01)

Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy
by: Celik E, et al.
Published: (2016-05-01)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
by: Mohammad Riazi-Esfahani, et al.
Published: (2008-12-01)

Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema
by: Cho M, et al.
Published: (2012-07-01)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
by: Yalamanchi S, et al.
Published: (2011-10-01)

Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
by: Arvind Kumar Dubey, et al.
Published: (2016-01-01)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
by: Juan Carlos Mesa Guti&eacute;rrez, et al.
Published: (2008-09-01)

Investigation of postoperative intraocular pressure in cases of silicone oil removal using 25-gauge transconjunctival sutureless vitrectomy with oblique incisions
by: Takashina H, et al.
Published: (2015-10-01)

Evaluation of the Findings of Patients Who Underwent Sutureless Flanged Transconjunctival Intrascleral Intraocular Lens Implantation with or without Pars Plana Vitrectomy
by: Elcin Suren, et al.
Published: (2021-01-01)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
by: Mehmet Demir, et al.
Published: (2013-07-01)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
by: Mehmet Demir, et al.
Published: (2013-01-01)

Predominantly hemorrhagic choroidal neovascular lesion from exsudative age-related macular degeneration treated with intravitreal ranibizumab therapy
by: Miguel Hage Amaro, et al.
Published: (2013-06-01)

Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
by: Boone NW, et al.
Published: (2012-01-01)

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
by: Ashraf M El-Batarny
Published: (2009-02-01)

Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration.
by: Jun Hyun Lim, et al.
Published: (2020-01-01)